Patient case studies. JR is a 72 YO male with CHF, LVEF=32%. T2DM, HTN His meds include carvedilol 12.5mg q12hr, furosemide 40mg q day, and kcl 20meq.

Slides:



Advertisements
Similar presentations
Long Distance Titration of Heart Failure Medications by Telephone Calls Anne E. Steckler, RN, Heba Wassif, MD, Kalkidan Bishu, MD, Gardar Sigurdsson, MD,
Advertisements

Practical Tips in β-blocker Therapy in CHF β-blocker Therapy in CHF CMCC 11 th 11 th September 2009 Rungsrit Kanjanavanit MD. Cardiovascular Div. Dept.
The Importance of Beta-Blockers in Patients with Heart Failure: A Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT) Analysis.
CLINICAL CASES.
ANGINA PECTORIS. Angina pectoris (chest pain) is the result of myocardial ischemia caused by an imbalance between myocardial blood supply and oxygen demand.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
חזק בהגנה לבבית Valsartan in Heart Failure
1 Heart Failure William Chavey, MD, MS Associate Professor Department of Family Medicine University of Michigan.
Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.
Corlanor® - Ivabradine
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
© 2000 Heart Failure Society of America, Inc.
Case Studies in Advanced Monitoring: OptiVol
Central Sleep Apnea Problem Based Learning Module Vidya Krishnan, and Sutapa Mukherjee for the Sleep Education for Pulmonary Fellows and Practitioners,
Dr. Jon Salisbury Visiting Physician Services A Member of VNA Health Group No Disclosures May 14, :40PM – 2:00PM ©AAHCM.
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Outpatient management of heart failure Dr. Rob Wu Feb 2008.
ATLAS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for Thrombosis and.
Indication:  Suspected Heart Failure With abnormal ECG or Intermediate BNP ( ) BNP:  Asymptomatic Murmur  Asymptomatic Cardiomegaly On CXR Direct.
Heart Failure Hazel Phillips Cardiac Support Nurse Bedford Hospital NHS Trust.
Heart Failure Management Applying the ACC/AHA Chronic Heart Failure Guidelines David Bragin Sánchez MD FACC Cardiomyopathy and Cardiac Transplant Specialist.
 A 59F diagnosed with HTN 8 years ago comes to the clinic for BP check. She is currently taking HCTZ 25 mg/d, lisinopril 40 mg/d and amlodipine 10 mg/d.
 Randomized controlled trials  Adults ≥ 18 years old with hypertension  N >100  Duration: ≥ 1 year  Outcomes  Mortality, CVD related-mortality,
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
2013 American College of Cardiology American Heart Association.
To understand about drug interaction in every day practice, and to refresh our memory to most common and important interactions.
Hypertension  Classification of hypertension  BP targets  Basic evaluation  When to evaluate for secondary causes  Which drug(s) you should use 
Heart Failure Pharmacology
Chronic Heart Failure Clinical case scenarios for primary care Educational Resource Implementing NICE guidance August 2010 NICE clinical guideline 108.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Patient case studies. JR is a 72 YO male with CHF, LVEF=32%. T2DM, HTN His meds include carvedilol 12.5mg q12hr, furosemide 40mg q day, and kcl 20meq.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
New Therapies Heather Kertland, PharmD. Eplerenone Ultrafiltration CRT Outline New Agents.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Jennifer Bell British Heart Foundation Heart Failure Nurse Specialist.
HYPERTENSION RECOMMENDATIONS FOR FOLLOW UP BASED ON INITIAL BP READING
Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.
Heart Failure Medications Zachary Cox, PharmD Associate Professor Lipscomb University College of Pharmacy Clinical Pharmacist, Vanderbilt University Medical.
HTN Cases Pharmacotherapy - 1. Case 1 TJ is a 45-year-old woman with a history of type 2 diabetes mellitus treated with glyburide 5 mg/ day. She.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
CURRENT APPROACH TO THE TREATMENT OF CONGESTIVE HEART FAILURE.
Internal Medicine Workshop Series Laos September /October 2009
Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Heart Failure: medication Types of Heart Failure Systolic (or squeezing) heart failure –Decreased pumping function of the heart, which results in fluid.
J.T. is a 62-year-old man with a history of CAD (MI 3 years ago), hypertension, depression, chronic renal insufficiency (baseline SCr is 2.8 mg/dL), peripheral.
Effect of some adrenergic drugs and its blockers on the blood pressure.
Pharmacokinetics: Digoxin Allie Punke
Management of Heart Failure Dr. M.Kheir Mulki. What is the definition of Heart Failure ?
Cardiac update for GPs - Chest pain/angina Sanjay Sastry Consultant Cardiologist Royal Bolton Hospital Royal Bolton Hospital Manchester Heart Centre Wigan.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
HEART FAILURE. Excellent Care 1. Diagnosis 2. ACE-I and B blocker 3. Aldosterone antagonist 4. Exercise 5. Statin and aspirin if CVD 6. Digoxin with AF.
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.
Managing Blood Pressure in the Older Adult Jamie McCarrell, Pharm.D., BCPS, CGP TTUHSC School of Pharmacy.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
+ Therapeutics 1 Tutoring Sarah Darby October 3, 2016.
Liver Disease tutoring Part 2
Udayan Bhatt, MD MPH OSU Nephrology
Anticoagulation in Atrial Fibrillation
HTN Cases Pharmacotherapy - 1.
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Section III: Neurohormonal strategies in heart failure
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
Background for understanding the Hypertension literature.
Jeannine Costigan RN(EC) Nurse Practitioner Heart Function Clinic
What is the relative risk reduction of ACEi’s/beta blockers for HFrEF?
Presentation transcript:

Patient case studies

JR is a 72 YO male with CHF, LVEF=32%. T2DM, HTN His meds include carvedilol 12.5mg q12hr, furosemide 40mg q day, and kcl 20meq q day. BP= 122/85 HR= 72 Scr= 0.1 … What drug would benefit the patient’s survival rate? A. Addition of Digoxin 0.125mg q day B. Addition of Lisinopril 2.5 mg q day C. Addition of Hydralazine 25mg q 8hr D. Addition of HCTZ 25 mg q day CASE 1

Answer: Lisinopril 2.5 mg q day. Beta-blockers, Ace-Inhibitors, and Spironolactone-antagonist are the medications associated with decreased mortality rate in Left-sided CHF. CASE 1- ANSWER

The previous pt in case 1, JR was started on Lisinopril 2.5 mg q day.. He has come back for a followup visit. What action should be taken? A. Decrease the dose of furosemide B. Increase the dose of Lisinopril C. No changes need take place D. Add diltiazem CD 120mg q day. CASE 2

Answer: Lisinopril dose should be increased. When implementing Beta-blockers and Ace-Inhibitors.. Start low and titrate up. 1 st the Beta-blocker for most effect, then the Ace- Inhibitor. CASE 2-ANSWER

The previous patient JR, comes in for a visit His lungs sound congested. His BNP= 4099 He is admitted and given IV furosemide, upon Discharge, what changes would be good. A. Add HCTZ 25 mg q day B. Add Spironolactone 25mg q day C. Increase Furosemide to 160 mg q day D. Enforce fluid restriction CASE 3

Answer: Aldactone-antagonist is one of the 3 drugs to increase survival. None of the other answers have shown to increase survival. Beta-Blocker decreases mortality 30% relative risk reduction Ace-Inhibitors decreases mortality 25-50% (depending on severity) Spironolactone decreases mortality 30% in NYHA class III & IV CASE-3 ANSWER

HR has CHF with LVEF= 40% and is on Bisoprolol 10mg/day. Per Recommendation of the pharmacy, Ramipril 2.5mg/day has been ordered Initial scr= 1.0… upon followup in 1 week, the scr climbs to What action should take place? A.Stop the Ramipril B.Decrease the dose of Ramipril to 1.25 C.No change in ramipril D.Change ramipril to Lisinopril 2.5mg q day CASE 4

The answer is to do nothing.. Typically the scr may rise up to 20% and is acceptable. ARF is rare. If the scr rises above the 20%, may consider stopping the ace- inhibitor. CASE 4- ANSWER

JJ comes to the hospital with heart failure, LVEF= 30%. When questioned about his decreased in physical activity. He says, he has no symptoms when watching TV, but finds he can’t finish mowing his front yard without total exhaustion. Which level of NYHA does he fall into? A.NYHA I B.NYHA 2 C.NYHA 3 D.NYHA 4 CASE #5

The answer is NYHA 3 NYHA 1--- No limitation in physical activity by HF symptoms NYHA 2--- Symptoms of HF with normal level of activity NYHA 3--- Marked limitations in physical activity because of HF symptoms NYHA 4--- Symptoms at rest. CASE #5- ANSWER

JJ is a 67 yo male with LVEF of 37% with atrial fib. He has a prosthetic mitral valve. He weighs 80 kg. scr= 1.1 crcl= 100. Which therapy should he be on? A.Enoxaparin 80 mg q 12 hr B.Enoxaparin 80 mg q 24 hr C.Warfarin 2.5 mg q day D.Apixaban 5 mg bid CASE #6

Answer: Warfarin 2.5 mg q day Since the patient has a prosthetic heart valve, warfarin is the only choice. None of the others are indicated for prothetic hear CASE #6-ANSWER

BT is admitted into the ER with CHF exacerbation. She is on metoprolol, Lisinopril, bumex, aspirin 81mg, cilostazol, and ibuprofen 800mg tid prn What changes should occur? A.Add Solu Medrol 125 mg q 8hrs B.Stop cilostazol and ibuprofen C.Increase aspirin to 325 mg D.Add lovenox CASE # 7

Stop cilostazol and ibupofen NSAID promote sodium and water retention. Cilostazol (an inhibitor of phosphodiesterase) is contraindicated in heart Failure. CASE #7 - ANSWER

TJ has CHF, LVEF= 22%, scr= 1.4 crcl=25 BP= 90/55 HR= 44 His meds include: Diltiazem 180mg CD, lisinopril 5 mg q12hr, spironolactone 25 mg q day. What actions should be taken? A.Add furosemide 40 mg iv bid B.Change Diltiazem to amlodipine 10 mg q day C.Add Metformin 500 mg q day D.Add aspirin 81 mg q day CASE # 8

Change Diltiazem to amlodipine. Diltiazem and verapamil have significant negative inotropic activity. LVEF is already at 22%... The calcium channel blockers amlodipine and felodipine Are safe to use and have minimal effect on the heart. CASE #8 - ANSWER

AR is an 89 YO male with a crcl= 32, wt= 51 kg with atrial fibrillation. He has been on long term warfarin, but can’t make the trip for the inr and wishes to try a new agent. Which one would you suggest? A.Rivaroxoban20 mg qday B.Adoxaban 60 mg q day C.Apixaban 2.5 mg bid D.Apixaban 5 mg bid CASE #9

Answer: Apixiban 2.5 mg bid Apixiban 5mg bid is wrong because wt < 60 kg, Adoxaban requires a dosage decrease for weight <= 60kg (needs 30mg qday).. Rivaroxaban should be dosed 15mg q day for crcl =15-50ml/min CASE #9-ANSWER

Jp is a 92 YO male with HTN and Rapid ventricular rate. He is Amlodipine 10 mg q day and hydralazine 25 mg tid. His HR= 120 and blood pressure is 170/110.. What medication would be most appropriate to try? 1. Switch amlodipine to verapamil 2. Switch hydralazine to Labetalol 3. Add dronedarone. 4. No change. CASE # 10

The answer is change hydralazine to labetalol. Labetolol has both calcium channel blocker activity for the HTN and a beta-blocker component for the fast heart rate. CASE # 10-ANSWER